Andecaliximab (Biosimilar Reference Antibody) (MMP9)
Andecaliximab (Biosimilar Reference Antibody) (MMP9)
Andecaliximab (Biosimilar Reference Antibody) (MMP9)-RA0490-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
ELISA plate pre-coated Antigen protein, can bind Andecaliximab (Biosimilar Reference Antibody) (MMP9)-RA0490 in a linear range of 3.91-125 ng/mL.
Andecaliximab (Biosimilar Reference Antibody) (MMP9)

Catalog: 

RA0490

Target

MMP9/GELB

Isotype

IgG4 - kappa

Applications

ELISA;FC;Functional Assays;IF

Reactivities

Human

Size ($):

100 μg-50;1 mg-210;5 mg-500;10 mg-800;25 mg-1750;50 mg-3000;100 mg-4600

Data Sheet

Material Safety Data Sheet

Certificate of Analysis

Product Description

Andecaliximab is a humanized IgG4 monoclonal antibody designed as a specific inhibitor of matrix metalloproteinase-9 (MMP-9). It was developed as a potential therapeutic agent for inflammatory diseases and cancer, with clinical trials primarily focusing on ulcerative colitis and gastric/gastroesophageal junction adenocarcinoma. The antibody functions by allosterically inhibiting the enzymatic activity of MMP-9, aiming to reduce tissue degradation, modulate the tumor microenvironment, and decrease inflammation. Despite advancing to Phase III trials in combination with chemotherapy for gastric cancer, its development was discontinued after the trial did not meet its primary endpoint of improving overall survival.

Synonyms

GS-5745

CAS

1518996-49-0

Isotype

IgG4 - kappa

Host

Chimeric

Target

MMP9/GELB

Reactivity

Human

Expression System

CHO

Applications

ELISA, FC, Functional Assays, IF; Recommended dilution: FC, IF:1:200

Purity

>98% by SDS-PAGE

Concentration

Bottled at the concentration indicated on the vial.

Buffer

0.01M PBS, pH 7.4, contains no stabilizers or preservatives.

Endotoxin

<1.0 EU/mg as determined by LAL method

Conjugation

Non-conjugated

Formulation

Liquid or Lyophilized powder Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Storage

store at -20°C or -80°C. Avoid repeated freeze.

Type

Antibody

Purposes

For research use only

References 1

Andrew E. Greenstein, et al. Effect of andecaliximab (anti-MMP9) on proteolysis of IL-7 in vitro, TCR diversity in mice, and serum IL-7 in gastric cancer patients in combination with chemotherapy. 2018 ASCO-SITC Clinical Immuno-Oncology Symposium.

References 2

Espindola MS, et al. Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 Feb 15;203(4):458-470.

References 3

References 4

References 5

Product Citations 1

Product Citations 2

https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.5_suppl.101
https://pubmed.ncbi.nlm.nih.gov/33052708/
https://www.oursmab.com/News/Matrix-metalloproteinase-MMP9.html

Target Description

Synonyms

matrix metallopeptidase 9, gelatinase B

Biology Area

Cancer Biology

Function

Matrix Metalloproteinase-9 (MMP-9; also known as gelatinase B), a zinc-dependent endopeptidase belonging to the MMP family. MMP-9 is secreted by various cell types including neutrophils, macrophages, and tumor cells. Its primary physiological and pathological function is the degradation of extracellular matrix (ECM) components, such as collagen IV and gelatin. In cancer, MMP-9 plays a multifaceted role in tumor progression, angiogenesis, invasion, and metastasis by remodeling the tissue stroma to facilitate cancer cell spread. In inflammation, it contributes to tissue damage and immune cell recruitment.

Additional Articles 1

Matrix-metalloproteinase-MMP9

Additional Articles 2

Related Products

Catalog: 

RA0490

Target:

CEACAM-1/CD66a

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0490

Target:

CD274/PDL1/B7H1

Isotype:

IgG - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0490

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0490

Target:

IL9

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0490

Target:

ILDR2

Isotype:

IgG2 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0490

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0490

Target:

IL6R/CD126

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0490

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0490

Target:

IL7R/CD127

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0490

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Contact Us

Send your request

Talk to us 

Get a quotation, discuss your requirement, receive advises from our antibody experts without obligation.